Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06608147

MOLyF : Bone Marrow and Follicular Lymphoma

Led by Rennes University Hospital · Updated on 2024-12-10

200

Participants Needed

1

Research Sites

512 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective single-center study designed to assess potential differences in cell composition between bone marrows of patients with follicular lymphoma and those from control subjects. Follicular lymphoma is the most common indolent lymphoma. It is characterised by systematic relapses and bone marrow dissemination in 70% of patients at the time of diagnosis. Although relapses are thought to be related to refractory tumour cells nested in a supportive microenvironment in the bone marrow, the mechanisms involved are poorly understood. To study the specificities of the bone marrow of patients with follicular lymphoma, It is necessary to compare them with control samples. This study takes advantage of surgeries involving sternotomies to recover lost bone marrow and establish a bone marrow bank of patients without hematological disease. This bank will be used to set up control cohorts for other clinical trials involving patients with follicular lymphoma.

CONDITIONS

Official Title

MOLyF : Bone Marrow and Follicular Lymphoma

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • Hospitalized in the thoracic, cardiac, or vascular surgery department for surgery involving a sternotomy
  • Provided free, informed, written consent
  • Covered by a health insurance scheme
Not Eligible

You will not qualify if you...

  • History of hematological malignancy or abnormal blood counts
  • Currently receiving immunomodulating treatments such as immunosuppressants, corticosteroids, or antineoplastic drugs
  • Individuals protected under French Public Health Code articles L. 1121-5 to L. 1121-8 and L. 1122-1-2, including minors and protected adults

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU Rennes

Rennes, France, 35009

Actively Recruiting

Loading map...

Research Team

J

Juliette Ferrant, MD

CONTACT

A

Alexandra Guerrier

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here